Philip L. Whitney

1.6k total citations
37 papers, 1.3k citations indexed

About

Philip L. Whitney is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Philip L. Whitney has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Physiology. Recurrent topics in Philip L. Whitney's work include Enzyme function and inhibition (8 papers), Neonatal Respiratory Health Research (7 papers) and Chemical Reactions and Mechanisms (5 papers). Philip L. Whitney is often cited by papers focused on Enzyme function and inhibition (8 papers), Neonatal Respiratory Health Research (7 papers) and Chemical Reactions and Mechanisms (5 papers). Philip L. Whitney collaborates with scholars based in United States and Sweden. Philip L. Whitney's co-authors include Charles Tanford, Janet T. Powell, Bo G. Malmström, Per Olof Nyman, Lee Frank, Dana McKinley, Daniel G. Baden, Linda Biadasz Clerch, Keith Brew and Michael A. Hass and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Philip L. Whitney

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip L. Whitney United States 19 781 200 182 177 130 37 1.3k
Jack E. Bodwell United States 26 1.2k 1.6× 95 0.5× 297 1.6× 61 0.3× 234 1.8× 48 2.5k
Sylvie Sauvaigo France 25 1.2k 1.6× 186 0.9× 66 0.4× 59 0.3× 22 0.2× 54 2.2k
Sofia Macedo Portugal 15 680 0.9× 175 0.9× 60 0.3× 32 0.2× 51 0.4× 31 1.6k
Elisabeth Fuchs Austria 18 399 0.5× 173 0.9× 57 0.3× 29 0.2× 30 0.2× 44 1.4k
Neil K. Gibbs United Kingdom 28 442 0.6× 335 1.7× 439 2.4× 47 0.3× 13 0.1× 66 2.0k
John L Tymoczko United States 20 819 1.0× 106 0.5× 88 0.5× 25 0.1× 19 0.1× 150 1.6k
Henry Hägerstrand Finland 27 1.4k 1.8× 189 0.9× 131 0.7× 31 0.2× 59 0.5× 95 2.1k
Nicholas P. Illsley United States 37 1.0k 1.3× 421 2.1× 398 2.2× 21 0.1× 25 0.2× 95 4.1k
Kazuhiro Matsushita Japan 19 546 0.7× 54 0.3× 54 0.3× 15 0.1× 65 0.5× 126 1.3k
Harry Sobotka United States 23 592 0.8× 30 0.1× 119 0.7× 41 0.2× 26 0.2× 83 1.8k

Countries citing papers authored by Philip L. Whitney

Since Specialization
Citations

This map shows the geographic impact of Philip L. Whitney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip L. Whitney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip L. Whitney more than expected).

Fields of papers citing papers by Philip L. Whitney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip L. Whitney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip L. Whitney. The network helps show where Philip L. Whitney may publish in the future.

Co-authorship network of co-authors of Philip L. Whitney

This figure shows the co-authorship network connecting the top 25 collaborators of Philip L. Whitney. A scholar is included among the top collaborators of Philip L. Whitney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip L. Whitney. Philip L. Whitney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Michael D., Nathalie Baumlin, Makoto Yoshida, et al.. (2019). Losartan Rescues Inflammation-Related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 201(3). 313–324. 32 indexed citations
2.
Holt, Gregory E., et al.. (2018). Differences in vaping topography in relation to adherence to exclusive electronic cigarette use in veterans. PLoS ONE. 13(4). e0195896–e0195896. 12 indexed citations
3.
Conner, Gregory E., et al.. (2013). H2O2 Stimulates Cystic Fibrosis Transmembrane Conductance Regulator through an Autocrine Prostaglandin Pathway, Using Multidrug-Resistant Protein–4. American Journal of Respiratory Cell and Molecular Biology. 49(4). 672–679. 22 indexed citations
4.
Whitney, Philip L. & Daniel G. Baden. (2006). Complex association and dissociation kinetics of brevetoxin binding to voltage-sensitive rat brain sodium channels. Natural Toxins. 4(6). 261–270. 5 indexed citations
5.
Campos, Michael, et al.. (2003). Purification and Characterization of PLUNC from Human Tracheobronchial Secretions. American Journal of Respiratory Cell and Molecular Biology. 30(2). 184–192. 69 indexed citations
6.
Naar, Jérôme, Andrea J. Bourdelais, Carmelo R. Tomas, et al.. (2002). A competitive ELISA to detect brevetoxins from Karenia brevis (formerly Gymnodinium breve) in seawater, shellfish, and mammalian body fluid.. Environmental Health Perspectives. 110(2). 179–185. 144 indexed citations
7.
Frank, Lee, et al.. (1996). Possible Mechanism for Late Gestational Development of the Antioxidant Enzymes in the Fetal Rat Lung. Neonatology. 70(2). 116–127. 36 indexed citations
8.
Chen, Youwei, Philip L. Whitney, & Lee Frank. (1994). Comparative Responses of Premature Versus Full-Term Newborn Rats to Prolonged Hyperoxia. Pediatric Research. 35(2). 233–237. 38 indexed citations
9.
Chen, Youwei, Philip L. Whitney, & Lee Frank. (1993). Negative Regulation of Antioxidant Enzyme Gene Expression in the Developing Fetal Rat Lung by Prenatal Hormonal Treatments. Pediatric Research. 33(2). 171–176. 15 indexed citations
10.
Whitney, Philip L., et al.. (1992). Soluble β-Galactoside Specific Lectin is Developmentally Regulated in Lungs of Neonatal Black Mice and Beige Mice. Experimental Lung Research. 18(4). 553–561. 1 indexed citations
11.
Whitney, Philip L.. (1989). Practical Disease Modelling with Fruits, Seeds, Bulbs and Tubers.. School science review. 70(254). 33–39. 64 indexed citations
12.
Clerch, Linda Biadasz, Philip L. Whitney, Michael A. Hass, et al.. (1988). Sequence of a full-length cDNA for rat lung .beta.-galactoside-binding protein: primary and secondary structure of the lectin. Biochemistry. 27(2). 692–699. 124 indexed citations
13.
Stein‐Streilein, Joan, et al.. (1987). Pulmonary Interstitial Fibrosis Induced in Hapten-Immune Hamsters. American Review of Respiratory Disease. 136(1). 119–123. 19 indexed citations
14.
Whitney, Philip L., et al.. (1987). Importance of the Mitochondrial Amino Acid Pool in the Sensitivity of Erythroid Cells to Chloramphenicol: Role of Glycine and Serine. Pharmacology. 35(6). 308–316. 5 indexed citations
16.
Mende, Thomas J. & Philip L. Whitney. (1978). Microdetermination of inorganic sulfate using thin-layer plates. Analytical Biochemistry. 84(2). 570–573. 15 indexed citations
17.
McKinley, Dana & Philip L. Whitney. (1976). Particulate carbonic anhydrase in homogenates of human kidney. Biochimica et Biophysica Acta (BBA) - Enzymology. 445(3). 780–790. 73 indexed citations
18.
Whitney, Philip L.. (1974). Affinity chromatography of carbonic anhydrase. Analytical Biochemistry. 57(2). 467–476. 67 indexed citations
19.
Whitney, Philip L. & Charles Tanford. (1965). RECOVERY OF SPECIFIC ACTIVITY AFTER COMPLETE UNFOLDING AND REDUCTION OF AN ANTIBODY FRAGMENT. Proceedings of the National Academy of Sciences. 53(3). 524–532. 60 indexed citations
20.
Buckley, C.E., Philip L. Whitney, & Charles Tanford. (1963). THE UNFOLDING AND RENATURATION OF A SPECIFIC UNIVALENT ANTIBODY FRAGMENT. Proceedings of the National Academy of Sciences. 50(5). 827–834. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026